APA (7th ed.) Citation

B, H., TN, O., X, Z., NK, C., W, C. L., LL, B., . . . C, A. (2021). Novel Humanized Mesothelin-Expressing Genetically Engineered Mouse Models Underscore Challenges in Delivery of Complex Therapeutics to Pancreatic Cancers. Molecular cancer therapeutics, 20(10), 2082. https://doi.org/10.1158/1535-7163.MCT-21-0017

Chicago Style (17th ed.) Citation

B, Hagerty, et al. "Novel Humanized Mesothelin-Expressing Genetically Engineered Mouse Models Underscore Challenges in Delivery of Complex Therapeutics to Pancreatic Cancers." Molecular Cancer Therapeutics 20, no. 10 (2021): 2082. https://doi.org/10.1158/1535-7163.MCT-21-0017.

MLA (9th ed.) Citation

B, Hagerty, et al. "Novel Humanized Mesothelin-Expressing Genetically Engineered Mouse Models Underscore Challenges in Delivery of Complex Therapeutics to Pancreatic Cancers." Molecular Cancer Therapeutics, vol. 20, no. 10, 2021, p. 2082, https://doi.org/10.1158/1535-7163.MCT-21-0017.